As yet another year begins, we have to wonder whether the healthcare system on which we all rely has ever witnessed such tumult. It comes to something when people in the UK – the civilised world, no ...

After a tumultuous election, the UK is left with a hung parliament and a minority government – a result few could have predicted just a few months ago. As an industry with deep connections in the UK, ...

It’s really heartening to see that the UK’s smaller, privately owned pharma sector continues to thrive in an operating environment peppered with uncertainty and financial restraint. Alantra’s annual ...

In our cover feature this month (p20), John Pinching considers the need for pharma to secure meaningful and sustainable engagement with rare disease patients, and how the challenge of doing so is ...

As part of our theme of celebrating positives in pharma and health during this difficult and turbulent time, while ensuring that we keep readers abreast of all the key developments amid the pandemic, ...

Go to the App Store or Google Play and search for ‘PharmaTimes’ to download our free app.

Do you have a new product, new business focus, or a company to showcase? Increase your exposure with a Business Insight in PharmaTimes Magazine. Our flexible package means you can submit your own copy ...

Though we mainly keep our eye on UK pharma at PharmaTimes, there’s no doubt that the industry here will have to become increasingly interconnected with other countries to face challenges ahead – and ...

Following months of heated debate in parliament and growing civil division, March 29 – the original date set for the UK’s separation from the European Union – looks set to pass amid yet more fighting ...

Perhaps the one ‘silver lining’ from the healthcare tumult and pandemic chaos of the past couple of years was a demonstration of unity between pharma, public health institutions and – pivotally – the ...